Parkinson's progression prediction using machine learning and serum cytokines | npj Parkinson's Disease
Major advances in Parkinson's disease over the past two decades and future research directions - The Lancet Neurology
Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease | ACS Chemical Neuroscience
Parkinson's disease: connecting mitochondria to inflammasomes: Trends in Immunology
Frontiers | Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned
Disentangling prodromal from non-prodromal symptoms of Parkinson's disease - MDS Abstracts
Cureus | The Correlation Between Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review | Article
The prediagnostic phase of Parkinson's disease | Journal of Neurology, Neurosurgery & Psychiatry
Prodromal Parkinson's disease: hype or hope for disease-modification trials? | Translational Neurodegeneration | Full Text
Frontiers | The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
Parkinson's disease - Wikipedia
Progress towards therapies for disease modification in Parkinson's disease - The Lancet Neurology
Prodromal Parkinson's disease: hype or hope for disease-modification trials? | Translational Neurodegeneration | Full Text
Mild Parkinsonian Signs in the Elderly – Is There an Association with PD? Crossectional Findings in 992 Individuals | PLOS ONE
Frontiers | Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
Frontiers | Clinical and Imaging Markers of Prodromal Parkinson's Disease
Frontiers | Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
.jpg "Parkinsons Disease - Course, Natural History and Prognosis - Neurotorium")
Parkinsons Disease - Course, Natural History and Prognosis - Neurotorium
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease | Molecular Medicine | Full Text
PDF) Blood Neurofilament Light Chain in Parkinson's Disease: Comparability between Parkinson's Progression Markers Initiative (PPMI) and Asian Cohorts
Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease | ACS Chemical Neuroscience
Prodromal PD: A new nosological entity - ScienceDirect
Parkinson's disease biomarkers based on α‐synuclein - Fayyad - 2019 - Journal of Neurochemistry - Wiley Online Library
Stages of Parkinson's disease (PD) and the biomarkers of interest. The... | Download Scientific Diagram
Advances in markers of prodromal Parkinson disease | Nature Reviews Neurology
